A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Torsemide (SOAANZ)

Torsemide removes excess fluid by acting on the kidneys, used in heart failure and edema.

First FDA approval2004-06-01
Generic availableYes · 6 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$90.6M in CY2024 Part D spend4.6M claims · 1.4M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.063/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.069
Across all dosage forms in distribution.
Highest NADAC
$0.073
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Torsemide used for?

Torsemide removes excess fluid by acting on the kidneys, used in heart failure and edema.

Is there a generic for Torsemide?

Yes. 25 ANDAs filed at FDA, 6 generic manufacturers currently shipping.

How much does my plan pay for Torsemide?

Across 329 Part D plans, Torsemide averages $0.069/unit (NADAC). Lowest available: $0.063/unit. Highest in distribution: $0.073/unit.

Is Torsemide on the FDA shortage list?

No. Torsemide is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Loop Diuretic4 alternatives in D1
01
Bumetanide
Brand: Bumex
$0.115Lowest NADAC
19Generic mfrs
$116.6MCY24 Part D spend
Compare →
02
Ethacrynic Acid
Brand: EDECRIN
$0.816Lowest NADAC
7Generic mfrs
$9.3MCY24 Part D spend
Compare →
03
Furosemide
Brand: LASIX ONYU
$0.027Lowest NADAC
21Generic mfrs
$231.6MCY24 Part D spend
Compare →
04
Furosemide Injection
Brand: FUROSCIX
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.